Mechanisms of Improvement of Glucose Metabolism in Patients with Type 2 Diabetes Mellitus after Treatment with Bariatric Surgery_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

陈博 ,  伍晓汀

Corresponding author：

伍晓汀, Email: wxt1@medmail.com.cn

Keywords：

2型糖尿病; 胃肠道手术; 外科治疗; 治疗机理

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 陈博,伍晓汀. Mechanisms of Improvement of Glucose Metabolism in Patients with Type 2 Diabetes Mellitus after Treatment with Bariatric Surgery. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2012, 19(12): 1283-1285. doi: Copy

1.	Yang W， Lu J， Wang J， et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med， 2010， 362(12)： 1090-1101.
2.	Mitka M. Bariatric surgery continues to show benefits for patients with diabetes[J]. JAMA， 2012， 307(18)：1901-1902.
3.	Schauer PR， Kashyap SR， Wolski K， et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes[J]. N Engl J Med， 2012， 366(17)：1567-1576.
4.	郑成竹，丁丹. 国内开展手术治疗糖尿病的原则及相关问题[J]. 中国实用外科杂志， 2010， 30(7)：574-577.
5.	丁丹，郑成竹. 手术治疗肥胖症及糖尿病——在共识与争议中发展[J]. 中国实用外科杂志， 2011， 31(1)：59-62.
6.	Chai F， Wang Y， Zhou Y， et al. Adiponectin downregulateshyperglycemia and reduces pancreatic islet apoptosis after Roux-en-Y gastric bypass surgery[J]. Obes Surg， 2011， 21(6)：768-773.
7.	Umeda LM， Silva EA， Carneiro G， et al. Early improvement in glycemic control after bariatric surgery and its relationships with insulin， GLP-1， and glucagon secretion in type 2 diabetic patients[J]. Obes Surg， 2011， 21(7)： 896-901.
8.	Flatt PR， Bailey CJ， Green BD. Recent advances in antidiabetic drug therapies targeting the enteroinsular axis[J]. Curr Drug Metab， 2009， 10(2)： 125-137.
9.	Flatt PR. Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP)： evidence and clinical opportunity for development of new obesity-diabetes drugs?[J]. Diab Vasc Dis Res， 2007， 4(2)：151-153.
10.	Pories WJ， Albrecht RJ. Etiology of typeⅡdiabetes mellitus：role of the foregut[J]. World J Surg， 2001， 25(4)：527-531.
11.	Aylwin S. Gastrointestinal surgery and gut hormones[J]. Curr Opin Endocrinol Diabetes， 2005， 12(1)：89-98.
12.	Cho YM， Kieffer TJ. New aspects of an old drug：metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser[J]. Diabetologia， 2011， 54(2)：219-222.
13.	Batterham RL， Cohen MA， Ellis SM， et al. Inhibition of food intake in obese subjects by peptide YY3-36[J]. N Engl J Med， 2003， 349(10)：941-948.
14.	Moo TA， Rubino F. Gastrointestinal surgery as treatment for type 2 diabetes[J]. Curr Opin Endocrinol Diabetes Obes， 2008， 15(2)：153-158.
15.	童颖丹，何剪太，张阳德. 2型糖尿病的外科治疗[J]. 中国现代医学杂志， 2011， 21(7)： 837-840.
16.	Vendrell J， Broch M， Vilarrasa N， et al. Resistin， adiponectin， ghrelin， leptin， and proinflammatory cytokines： relationships in obesity[J]. Obes Res， 2004， 12(6)：962-971.
17.	Hindle AK， Edwards C， McCaffrey T， et al. Reactivation of adiponectin expression in obese patients after bariatric surgery[J]. Surg Endosc， 2010， 24(6)：1367-1373.
18.	Prospective Studies Collaboration；Whitlock G， Lewington S， et al. Body-mass index and cause-specific mortality in 900 000 adults：collaborative analyses of 57 prospective studies[J]. Lancet， 2009， 373(9669)：1083-1096.
19.	Hotamisligil GS. Inflammation and metabolic disorders[J].Nature， 2006， 444(7121)：860-867.
20.	Toghaw P， Matone A， Lenbury Y， et al. Bariatric surgery and T2DM improvement mechanisms： a mathematical model[J]. Theor Biol Med Model， 2012， 9(1)：16.
21.	Ferchak CV， Meneghini LF. Obesity， bariatric surgery and type 2 diabetes——a systematic review[J]. Diabetes Metab Res Rev， 2004， 20(6)：438-445.

1. Yang W， Lu J， Wang J， et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med， 2010， 362(12)： 1090-1101.
2. Mitka M. Bariatric surgery continues to show benefits for patients with diabetes[J]. JAMA， 2012， 307(18)：1901-1902.
3. Schauer PR， Kashyap SR， Wolski K， et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes[J]. N Engl J Med， 2012， 366(17)：1567-1576.
4. 郑成竹，丁丹. 国内开展手术治疗糖尿病的原则及相关问题[J]. 中国实用外科杂志， 2010， 30(7)：574-577.
5. 丁丹，郑成竹. 手术治疗肥胖症及糖尿病——在共识与争议中发展[J]. 中国实用外科杂志， 2011， 31(1)：59-62.
6. Chai F， Wang Y， Zhou Y， et al. Adiponectin downregulateshyperglycemia and reduces pancreatic islet apoptosis after Roux-en-Y gastric bypass surgery[J]. Obes Surg， 2011， 21(6)：768-773.
7. Umeda LM， Silva EA， Carneiro G， et al. Early improvement in glycemic control after bariatric surgery and its relationships with insulin， GLP-1， and glucagon secretion in type 2 diabetic patients[J]. Obes Surg， 2011， 21(7)： 896-901.
8. Flatt PR， Bailey CJ， Green BD. Recent advances in antidiabetic drug therapies targeting the enteroinsular axis[J]. Curr Drug Metab， 2009， 10(2)： 125-137.
9. Flatt PR. Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP)： evidence and clinical opportunity for development of new obesity-diabetes drugs?[J]. Diab Vasc Dis Res， 2007， 4(2)：151-153.
10. Pories WJ， Albrecht RJ. Etiology of typeⅡdiabetes mellitus：role of the foregut[J]. World J Surg， 2001， 25(4)：527-531.
11. Aylwin S. Gastrointestinal surgery and gut hormones[J]. Curr Opin Endocrinol Diabetes， 2005， 12(1)：89-98.
12. Cho YM， Kieffer TJ. New aspects of an old drug：metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser[J]. Diabetologia， 2011， 54(2)：219-222.
13. Batterham RL， Cohen MA， Ellis SM， et al. Inhibition of food intake in obese subjects by peptide YY3-36[J]. N Engl J Med， 2003， 349(10)：941-948.
14. Moo TA， Rubino F. Gastrointestinal surgery as treatment for type 2 diabetes[J]. Curr Opin Endocrinol Diabetes Obes， 2008， 15(2)：153-158.
15. 童颖丹，何剪太，张阳德. 2型糖尿病的外科治疗[J]. 中国现代医学杂志， 2011， 21(7)： 837-840.
16. Vendrell J， Broch M， Vilarrasa N， et al. Resistin， adiponectin， ghrelin， leptin， and proinflammatory cytokines： relationships in obesity[J]. Obes Res， 2004， 12(6)：962-971.
17. Hindle AK， Edwards C， McCaffrey T， et al. Reactivation of adiponectin expression in obese patients after bariatric surgery[J]. Surg Endosc， 2010， 24(6)：1367-1373.
18. Prospective Studies Collaboration；Whitlock G， Lewington S， et al. Body-mass index and cause-specific mortality in 900 000 adults：collaborative analyses of 57 prospective studies[J]. Lancet， 2009， 373(9669)：1083-1096.
19. Hotamisligil GS. Inflammation and metabolic disorders[J].Nature， 2006， 444(7121)：860-867.
20. Toghaw P， Matone A， Lenbury Y， et al. Bariatric surgery and T2DM improvement mechanisms： a mathematical model[J]. Theor Biol Med Model， 2012， 9(1)：16.
21. Ferchak CV， Meneghini LF. Obesity， bariatric surgery and type 2 diabetes——a systematic review[J]. Diabetes Metab Res Rev， 2004， 20(6)：438-445.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Mechanisms of Improvement of Glucose Metabolism in Patients with Type 2 Diabetes Mellitus after Treatment with Bariatric Surgery

Abstract Full text Figures/Tables Video References Cited by

Format

Content